Announcements Trials

Browse Landscape

Phase

Status

Active not recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Tumor-Agnostic 1 Head & Neck 1

Conditions

Head and Neck Neoplasms 1

Interventions

pembrolizumab 66 Cisplatin 55 Radiotherapy, Intensity-Modulated 28 Carboplatin 27 Nivolumab 26 Paclitaxel 21 Magnetic Resonance Spectroscopy 21 Radiotherapy 20 Cetuximab 16 Specimen Handling 15 Docetaxel 15 Radiation 14 Gemcitabine 13 Fluorouracil 12 Biopsy 12 durvalumab 11 Platinum 11 Taxes 10 Drug Therapy 10 1,2-diaminocyclohexaneplatinum II citrate 10 Surveys and Questionnaires 9 Capecitabine 9 trametinib 8 tislelizumab 6 lenvatinib 6 dabrafenib 6 cemiplimab 6 atezolizumab 6 Radiosurgery 6 Ipilimumab 6

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Active not recruiting × Amyloid × Head & Neck × Clear all

NCT05997329 2025-09-08

NUTREAT

University of Oslo

Phase NA Active not recruiting

Head and Neck Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡